BACKGROUND Polycystic ovary syndrome (PCOS) is the most common cause of
anovulatory infertility. An endometrial component has been suggested to contribute to …

Abstract BACKGROUND Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs)
have become firmly established in the treatment of type 2 diabetes and obesity, disorders …

Abstract Objective Glucagon-like peptide-1 (GLP-1) has been investigated in regulation of
reproductive system in animal models. The potential impact of short-term preconception …

Context Up to 40% of patients with polycystic ovary syndrome (PCOS) have prediabetes; an
optimal pharmacotherapy regimen for diabetes prevention in PCOS is yet to be established …

Lifestyle measures (LSMs) should be the first-line approach offered for obesity-related
functional hypogonadism (FH). When LSMs fail, the role of testosterone replacement …

Currently, gastrointestinal hormone glucagon like peptide-1 (GLP-1) has received significant
attention in maintaining glucose homeostasis through mechanisms involving augmentation …

Abstract Purpose The majority of Polycystic ovary syndrome (PCOS) are overweight or
obese with increased infertility and high risk of pregnancy complications. We aim to compare …

Direct and indirect evidence suggest that the endometrial receptivity may play a crucial role
in the reduced fertility rate of women with polycystic ovary syndrome (PCOS). Various …

Abstract Despite Polycystic Ovary Syndrome (PCOS) is a very prevalent disorder among
women of reproductive age, there is widespread agreement that until now, no …

Increasing infertility rates represent a growing medical challenge in modern societies
resulting from a complex interplay of sociocultural trends, lifestyle factors, exposure to …